IL-1R1 and IL-18 signals regulate mesenchymal stromal cells in an aged murine model of myelodysplastic syndromes

2.

Sperling

AS

,

Gibson

CJ

,

Ebert

BL

.

The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia

.

Nat Rev Cancer

.

2017

;

17

(

1

):

5

-

19

.

3.

Epling-Burnette

PK

,

List

AF

.

Advancements in the molecular pathogenesis of myelodysplastic syndrome

.

Curr Opin Hematol

.

2009

;

16

(

2

):

70

-

76

.

4.

Ogawa

S

.

Genetics of MDS

.

Blood

.

2019

;

133

(

10

):

1049

-

1059

.

5.

Cazzola

M

,

Della Porta

MG

,

Malcovati

L

.

The genetic basis of myelodysplasia and its clinical relevance

.

Blood

.

2013

;

122

(

25

):

4021

-

4034

.

6.

Calvi

LM

,

Link

DC

.

Cellular complexity of the bone marrow hematopoietic stem cell niche

.

Calcif Tissue Int

.

2014

;

94

(

1

):

112

-

124

.

7.

Pinho

S

,

Frenette

PS

.

Haematopoietic stem cell activity and interactions with the niche

.

Nat Rev Mol Cell Biol

.

2019

;

20

(

5

):

303

-

320

.

8.

Ridge

SM

,

Sullivan

FJ

,

Glynn

SA

.

Mesenchymal stem cells: key players in cancer progression

.

Mol Cancer

.

2017

;

16

(

1

):

31

.

9.

Mendez-Ferrer

S

,

Michurina

TV

,

Ferraro

F

, et al.

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

.

Nature

.

2010

;

466

(

7308

):

829

-

834

.

10.

Pinho

S

,

Lacombe

J

,

Hanoun

M

, et al.

PDGFRα and CD51 mark human nestin⁺ sphere^–forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion

.

J Exp Med

.

2013

;

210

(

7

):

1351

-

1367

.

11.

Ding

L

,

Saunders

TL

,

Enikolopov

G

,

Morrison

SJ

.

Endothelial and perivascular cells maintain haematopoietic stem cells

.

Nature

.

2012

;

481

(

7382

):

457

-

462

.

12.

Sugiyama

T

,

Kohara

H

,

Noda

M

,

Nagasawa

T

.

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

.

Immunity

.

2006

;

25

(

6

):

977

-

988

.

13.

Pronk

E

,

Raaijmakers

M

.

The mesenchymal niche in MDS

.

Blood

.

2019

;

133

(

10

):

1031

-

1038

.

14.

Li

AJ

,

Calvi

LM

.

The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression

.

Exp Hematol

.

2017

;

55

:

3

-

18

.

15.

Raaijmakers

MH

,

Mukherjee

S

,

Guo

S

, et al.

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

.

Nature

.

2010

;

464

(

7290

):

852

-

857

.

16.

Kode

A

,

Manavalan

JS

,

Mosialou

I

, et al.

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

.

Nature

.

2014

;

506

(

7487

):

240

-

244

.

17.

Zambetti

NA

,

Ping

Z

,

Chen

S

, et al.

Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia

.

Cell Stem Cell

.

2016

;

19

(

5

):

613

-

627

.

18.

Dong

L

,

Yu

WM

,

Zheng

H

, et al.

Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment

.

Nature

.

2016

;

539

(

7628

):

304

-

308

.

19.

Walkley

CR

,

Shea

JM

,

Sims

NA

,

Purton

LE

,

Orkin

SH

.

Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment

.

Cell

.

2007

;

129

(

6

):

1081

-

1095

.

20.

Walkley

CR

,

Olsen

GH

,

Dworkin

S

, et al.

A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency

.

Cell

.

2007

;

129

(

6

):

1097

-

1110

.

21.

Kim

YW

,

Koo

BK

,

Jeong

HW

, et al.

Defective Notch activation in microenvironment leads to myeloproliferative disease

.

Blood

.

2008

;

112

(

12

):

4628

-

4638

.

22.

Geyh

S

,

Oz

S

,

Cadeddu

RP

, et al.

Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

.

Leukemia

.

2013

;

27

(

9

):

1841

-

1851

.

https://doi.org/10.1101/2023.04.09.536176

23.

Kawano

Y

,

Kawano

H

,

Ghoneim

D

, et al.

Myelodysplastic syndromes disable human CD271⁺VCAM1⁺CD146⁺ niches supporting normal hematopoietic stem/progenitor cells

.

bioRxiv

.

Preprint posted online 28 April 2023

.

24.

Azadniv

M

,

Myers

JR

,

McMurray

HR

, et al.

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support

.

Leukemia

.

2020

;

34

(

2

):

391

-

403

.

25.

Balderman

SR

,

Li

AJ

,

Hoffman

CM

, et al.

Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome

.

Blood

.

2016

;

127

(

5

):

616

-

625

.

26.

Frisch

BJ

,

Hoffman

CM

,

Latchney

SE

, et al.

Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B

.

JCI Insight

.

2019

;

5

(

10

):

e124213

.

27.

Litmanovich

A

,

Khazim

K

,

Cohen

I

.

The role of interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice

.

Oncol Ther

.

2018

;

6

(

2

):

109

-

127

.

28.

Lin

YW

,

Slape

C

,

Zhang

Z

,

Aplan

PD

.

NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia

.

Blood

.

2005

;

106

(

1

):

287

-

295

.

29.

Kawano

Y

,

Kawano

H

,

Busch

S

, et al.

Persistent contamination by bone and bone marrow-derived macrophages obscures functional assessment of tissue-dependent heterogeneity in mesenchymal stromal cells [abstract]

.

Blood

.

2023

;

142

(

suppl 1

):

5623

.

30.

Ho

TC

,

LaMere

M

,

Stevens

BM

, et al.

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

.

Blood

.

2016

;

128

(

13

):

1671

-

1678

.

31.

Kilkenny

C

,

Browne

WJ

,

Cuthill

IC

,

Emerson

M

,

Altman

DG

.

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

.

PLoS Biol

.

2010

;

8

(

6

):

e1000412

.

32.

McColl

SR

,

Clark-Lewis

I

.

Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists

.

J Immunol

.

1999

;

163

(

5

):

2829

-

2835

.

33.

Paudel

S

,

Baral

P

,

Ghimire

L

, et al.

CXCL1 regulates neutrophil homeostasis in pneumonia-derived sepsis caused by Streptococcus pneumoniae serotype 3

.

Blood

.

2019

;

133

(

12

):

1335

-

1345

.

34.

Kfoury

YS

,

Ji

F

,

Jain

E

, et al.

The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression

.

Blood Adv

.

2023

;

7

(

21

):

6608

-

6623

.

35.

Zhao

H

,

Chen

Q

,

Alam

A

, et al.

The role of osteopontin in the progression of solid organ tumour

.

Cell Death Dis

.

2018

;

9

(

3

):

356

.

36.

Legros

L

,

Slama

B

,

Karsenti

JM

, et al.

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

.

Ann Hematol

.

2012

;

91

(

1

):

39

-

46

.

37.

Silberstein

L

,

Goncalves

KA

,

Kharchenko

PV

, et al.

Proximity-based differential single-cell analysis of the niche to identify stem/progenitor cell regulators

.

Cell Stem Cell

.

2016

;

19

(

4

):

530

-

543

.

38.

Ogawa

M

,

Nishikawa

S

,

Ikuta

K

, et al.

B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac

.

EMBO J

.

1988

;

7

(

5

):

1337

-

1343

.

39.

Pronk

CJ

,

Rossi

DJ

,

Mansson

R

, et al.

Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy

.

Cell Stem Cell

.

2007

;

1

(

4

):

428

-

442

.

40.

Morikawa

S

,

Mabuchi

Y

,

Kubota

Y

, et al.

Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow

.

J Exp Med

.

2009

;

206

(

11

):

2483

-

2496

.

41.

Greenbaum

A

,

Hsu

YM

,

Day

RB

, et al.

CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance

.

Nature

.

2013

;

495

(

7440

):

227

-

230

.

42.

Choumerianou

DM

,

Martimianaki

G

,

Stiakaki

E

,

Kalmanti

L

,

Kalmanti

M

,

Dimitriou

H

.

Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults

.

Cytotherapy

.

2010

;

12

(

7

):

881

-

887

.

43.

Glaccum

MB

,

Stocking

KL

,

Charrier

K

, et al.

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1

.

J Immunol

.

1997

;

159

(

7

):

3364

-

3371

.

44.

Okamura

H

,

Tsutsi

H

,

Komatsu

T

, et al.

Cloning of a new cytokine that induces IFN-gamma production by T cells

.

Nature

.

1995

;

378

(

6552

):

88

-

91

.

45.

Ushio

S

,

Namba

M

,

Okura

T

, et al.

Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein

.

J Immunol

.

1996

;

156

(

11

):

4274

-

4279

.

46.

Feng

X

,

Scheinberg

P

,

Wu

CO

, et al.

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes

.

Haematologica

.

2011

;

96

(

4

):

602

-

606

.

47.

Shi

X

,

Zheng

Y

,

Xu

L

,

Cao

C

,

Dong

B

,

Chen

X

.

The inflammatory cytokine profile of myelodysplastic syndromes: a meta-analysis

.

Medicine (Baltimore)

.

2019

;

98

(

22

):

e15844

.

48.

Kornblau

SM

,

McCue

D

,

Singh

N

,

Chen

W

,

Estrov

Z

,

Coombes

KR

.

Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia

.

Blood

.

2010

;

116

(

20

):

4251

-

4261

.

49.

Schneider

M

,

Rolfs

C

,

Trumpp

M

, et al.

Activation of distinct inflammatory pathways in subgroups of LR-MDS

.

Leukemia

.

2023

;

37

(

8

):

1709

-

1718

.

50.

Elzinga

BM

,

Twomey

C

,

Powell

JC

,

Harte

F

,

McCarthy

JV

.

Interleukin-1 receptor type 1 is a substrate for gamma-secretase-dependent regulated intramembrane proteolysis

.

J Biol Chem

.

2009

;

284

(

3

):

1394

-

1409

.

51.

Italiani

P

,

Puxeddu

I

,

Napoletano

S

, et al.

Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?

.

J Neuroinflammation

.

2018

;

15

(

1

):

342

.

52.

Arend

WP

,

Malyak

M

,

Smith

MF

, et al.

Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids

.

J Immunol

.

1994

;

153

(

10

):

4766

-

4774

.

53.

Pittenger

MF

,

Discher

DE

,

Peault

BM

,

Phinney

DG

,

Hare

JM

,

Caplan

AI

.

Mesenchymal stem cell perspective: cell biology to clinical progress

.

NPJ Regen Med

.

2019

;

4

:

22

.

54.

Lee

JK

,

Kim

SH

,

Lewis

EC

,

Azam

T

,

Reznikov

LL

,

Dinarello

CA

.

Differences in signaling pathways by IL-1beta and IL-18

.

Proc Natl Acad Sci U S A

.

2004

;

101

(

23

):

8815

-

8820

.

55.

Singer

JW

,

Fleischman

A

,

Al-Fayoumi

S

,

Mascarenhas

JO

,

Yu

Q

,

Agarwal

A

.

Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy

.

Oncotarget

.

2018

;

9

(

70

):

33416

-

33439

.

56.

Mertens

M

,

Singh

JA

.

Anakinra for rheumatoid arthritis

.

Cochrane Database Syst Rev

.

2009

(

1

):

CD005121

.

57.

Khani

E

,

Shahrabi

M

,

Rezaei

H

,

Pourkarim

F

,

Afsharirad

H

,

Solduzian

M

.

Current evidence on the use of anakinra in COVID-19

.

Int Immunopharmacol

.

2022

;

111

:

109075

.

58.

Martinon

F

,

Burns

K

,

Tschopp

J

.

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

.

Mol Cell

.

2002

;

10

(

2

):

417

-

426

.

59.

Coll

RC

,

Robertson

AA

,

Chae

JJ

, et al.

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

.

Nat Med

.

2015

;

21

(

3

):

248

-

255

.